BSW Wealth Partners Boosts Stock Holdings in Agilent Technologies, Inc. $A

BSW Wealth Partners raised its stake in Agilent Technologies, Inc. (NYSE:A) by 8.4% during the second quarter, Holdings Channel reports. The firm owned 5,316 shares of the medical research company’s stock after purchasing an additional 413 shares during the period. BSW Wealth Partners’ holdings in Agilent Technologies were worth $627,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. OLD Point Trust & Financial Services N A boosted its holdings in Agilent Technologies by 4.6% in the second quarter. OLD Point Trust & Financial Services N A now owns 7,304 shares of the medical research company’s stock valued at $862,000 after acquiring an additional 323 shares during the last quarter. PFG Investments LLC increased its stake in Agilent Technologies by 6.4% during the second quarter. PFG Investments LLC now owns 2,375 shares of the medical research company’s stock worth $280,000 after acquiring an additional 142 shares during the last quarter. Cooper Financial Group raised its holdings in shares of Agilent Technologies by 21.8% in the 2nd quarter. Cooper Financial Group now owns 2,199 shares of the medical research company’s stock worth $260,000 after purchasing an additional 394 shares during the period. JLB & Associates Inc. lifted its stake in shares of Agilent Technologies by 1.9% in the 2nd quarter. JLB & Associates Inc. now owns 29,652 shares of the medical research company’s stock valued at $3,499,000 after purchasing an additional 540 shares in the last quarter. Finally, Capital Investment Advisors LLC lifted its stake in shares of Agilent Technologies by 7.8% in the 2nd quarter. Capital Investment Advisors LLC now owns 3,027 shares of the medical research company’s stock valued at $357,000 after purchasing an additional 218 shares in the last quarter.

Agilent Technologies Price Performance

Shares of A stock opened at $138.75 on Thursday. The company has a market capitalization of $39.34 billion, a PE ratio of 32.57, a price-to-earnings-growth ratio of 4.19 and a beta of 1.26. The firm has a fifty day simple moving average of $122.00 and a 200-day simple moving average of $116.17. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $153.84.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.37. The firm had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The firm’s quarterly revenue was up 10.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Equities research analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th will be issued a dividend of $0.248 per share. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 annualized dividend and a yield of 0.7%. Agilent Technologies’s payout ratio is currently 23.24%.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on A shares. Robert W. Baird raised their price target on shares of Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a report on Thursday, August 28th. Evercore ISI dropped their price objective on shares of Agilent Technologies from $130.00 to $128.00 and set an “in-line” rating for the company in a research report on Thursday, August 28th. Wells Fargo & Company raised their target price on shares of Agilent Technologies from $140.00 to $150.00 and gave the company an “overweight” rating in a research note on Monday, September 15th. Wall Street Zen lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Friday, September 5th. Finally, Barclays reiterated an “equal weight” rating and issued a $125.00 price target on shares of Agilent Technologies in a report on Friday, August 29th. Six equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $140.08.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.